---
title: New Research on NEXGEL, Inc. (NXGL-NASDAQ)
description: Crystal Research Associates has released a 20-page report on NEXGEL, Inc., a maker of hydrogels for skin and wound care.
---

[Crystal Research Associates' Blog ](https://www.crystalra.com/blog)

# [New Research on NEXGEL, Inc. (NXGL-NASDAQ)](https://www.crystalra.com/blog/nexgel)

 Written by [Karen Goldfarb](https://www.crystalra.com/blog/author/karen-goldfarb) | June 30, 2025 at 5:57 PM

A new Executive Informational Summary is now available on NEXGEL, Inc. (NASDAQ: NXGL), a company developing skin-friendly hydrogels for use in healthcare, cosmetics, and wellness. This 20-page report explores NEXGEL’s business model, growth strategy, market opportunity, competitive landscape, and key risks. Download the full report below.

**Snapshot**

<https://www.crystalra.com/hubfs/SATELLOS_Executive-Informational-Overview_10-05-23.pdf><https://www.crystalra.com/hubfs/NEXGEL_Executive_Summary_06-30-2025_F.pdf>

NEXGEL, Inc. (NXGL-NASDAQ) is a biotechnology company specializing in the development and manufacturing of advanced, high-water-content hydrogels for use in healthcare, medical device, cosmetic, and consumer wellness applications. Headquartered in Langhorne, Pennsylvania, the Company operates an FDA-registered and ISO-certified facility utilizing a proprietary electron-beam cross-linking process to produce ultra-gentle, skin-friendly hydrogel formulations. This technology enables long-lasting, breathable patches that deliver active ingredients through the skin without irritation or the use of chemical cross-linkers—making NEXGEL’s products ideal for wound care, scar treatment, drug delivery, and sensitive-skin cosmetics. The Company’s portfolio includes branded products such as SilverSeal®, MEDAGEL®, Turfguard®, and Kenkoderm®, as well as white-label manufacturing solutions. NEXGEL also offers contract development and packaging services through its CG Converting & Packaging subsidiary, allowing it to serve a wide range of clients across healthcare and consumer markets. Recent acquisitions, including the Silly George® beauty brand, reflect the Company’s strategic expansion into global personal care. With a scalable infrastructure, proprietary intellectual property (IP), and growing demand across multiple sectors, NEXGEL is well-positioned to lead innovation in topical delivery systems.

**Key Points of NEXGEL, Inc.**

- ***Innovative Hydrogel Technology Platform.*** NEXGEL’s proprietary hydrogels provide superior adhesion, breathability, and comfort for wound care, drug delivery, medical devices, and consumer health products.
- ***Diversified Business Model.*** The Company generates revenue from branded over-the-counter (OTC), private label, and Contract Development and Manufacturing Organization (CDMO) channels, providing flexibility, scale, and reduced market dependence.
- ***Integrated cGMP Manufacturing.*** NEXGEL’s FDA-compliant facility enables in-house research and development (R&D), production, and rapid innovation with quality control.
- ***Expanding IP Portfolio.*** The Company holds 17 active patents with additional filings covering formulations, processes, and applications.
- ***Strong Growth and Margins.*** NEXGEL’s Q1 2025 revenue rose 121% to $2.81 million, with gross margin improving to 42.4% on greater scale and efficiency.
- ***Solid Cash Position. ***As of March 31, 2025, NEXGEL had $1.19 million in cash to support operations and growth toward EBITDA breakeven. 

***********************************************

Visit our [Corporate Profile](https://www.crystalra.com/nexgel-inc) and [Investment Highlights](https://www.crystalra.com/nexgel-inc.-investment-highlights)<https://www.crystalra.com/magnegas-key-points>pages

for the latest research on NEXGEL, Inc.

***********************************************

 

[View full post](https://www.crystalra.com/blog/nexgel)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Karen Goldfarb"
  },
  "dateModified" : "2025-06-30T19:17:05.689Z",
  "datePublished" : "2025-06-30T17:57:20Z",
  "headline" : "New Research on NEXGEL, Inc. (NXGL-NASDAQ)",
  "image" : {
    "@type" : "ImageObject",
    "height" : 900,
    "url" : "https://150154.fs1.hubspotusercontent-na1.net/hubfs/150154/NEXGEL%2c%20Inc.%20report-2.png",
    "width" : 1600
  },
  "mainEntityOfPage" : "https://www.crystalra.com/blog/nexgel",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "Blog"
  }
}
```